Viavi (VIAV) Form 144 Files Proposed Sale of 8,385 Shares
Rhea-AI Filing Summary
Form 144 filed for Viavi Solutions, Inc. (VIAV) reports a proposed sale of 8,385 Common shares through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $95,067.45. The filer indicates the shares were acquired as restricted stock on 02/22/2017 from the issuer and payment was noted as not applicable. The filing lists the issuer's outstanding shares as 223,245,915, and an approximate sale date of 09/02/2025. The notice also discloses two prior sales by Richard E. Belluzzo in the past three months: 8,385 shares on 08/01/2025 for $81,500.52 and 8,385 shares on 07/01/2025 for $83,984.16. The filer certifies there is no undisclosed material adverse information and includes the standard signature representation.
Positive
- Complete Rule 144 disclosure including broker, acquisition details, recent sales and certification enhances transparency
Negative
- None.
Insights
TL;DR: Routine Form 144 reporting an insider sale of 8,385 shares; size is immaterial versus outstanding shares.
The filing documents a proposed sale of 8,385 common shares by an insider using Morgan Stanley Smith Barney, valued at $95,067.45. Compared with the issuer's reported 223,245,915 outstanding shares, the position is a very small fraction of equity, suggesting limited direct market impact. The filing also records two recent monthly sales of identical share amounts in July and August 2025, indicating ongoing disposition activity rather than a single transaction. Disclosure appears complete for Rule 144 purposes, including acquisition method (restricted stock) and required representations.
TL;DR: Compliance-focused filing; repeated small sales disclosed and signed with standard certifications.
The Form 144 includes necessary elements: broker name and address, class, number of shares, aggregate market value, acquisition date and nature (restricted stock), and recent sales in the past three months by the same person. The representation that the filer is unaware of undisclosed material adverse information and the signature notice satisfy certification requirements. From a governance perspective, the document evidences transparent reporting of insider dispositions but does not by itself indicate governance issues.